|
Immunotherapy
Citations 121-130 of 577 total displayed.
|
Past content
(since Jun 2000):
|
A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3/CD28 costimulation
- David L. Porter, Bruce L. Levine, Nancy Bunin, Edward A. Stadtmauer, Selina M. Luger, Steven Goldstein, Alison Loren, Julie Phillips, Sunita Nasta, Alexander Perl, Steven Schuster, Donald Tsai, Ambika Sohal, Elizabeth Veloso, Stephen Emerson, and Carl H. June
Blood 2006; 107: 1325-1331.
[Abstract]
[Full text]
[PDF]
Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell transplantation
- Raphaël F. Rousseau, Ettore Biagi, Aurélie Dutour, Eric S. Yvon, Michael P. Brown, Tiffany Lin, Zhuyong Mei, Bambi Grilley, Edwina Popek, Helen E. Heslop, Adrian P. Gee, Robert A. Krance, Uday Popat, George Carrum, Judith F. Margolin, and Malcolm K. Brenner
Blood 2006; 107: 1332-1341.
[Abstract]
[Full text]
[PDF]
NK-cell activation by LIGHT triggers tumor-specific CD8+ T-cell immunity to reject established tumors
- Zusen Fan, Ping Yu, Yang Wang, Yugang Wang, May Lynne Fu, Wenhua Liu, Yonglian Sun, and Yang-Xin Fu
Blood 2006; 107: 1342-1351.
[Abstract]
[Full text]
[PDF]
Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720
- Barbara Zemann, Bernd Kinzel, Matthias Müller, Roland Reuschel, Diana Mechtcheriakova, Nicole Urtz, Frédéric Bornancin, Thomas Baumruker, and Andreas Billich
Blood 2006; 107: 1454-1458.
[Abstract]
[Full text]
[PDF]
Dendritic-cell-associated C-type lectin 2 (DCAL-2) alters dendritic-cell maturation and cytokine production
- Chang-Hung Chen, Helen Floyd, N. Eric Olson, Dario Magaletti, Chang Li, Kevin Draves, and Edward A. Clark
Blood 2006; 107: 1459-1467.
[Abstract]
[Full text]
[PDF]
The kinase insert domain-containing receptor is an angiogenesis-associated antigen recognized by human cytotoxic T lymphocytes
- Yuansheng Sun, Stefan Stevanovic, Mingxia Song, Astrid Schwantes, C. James Kirkpatrick, Dirk Schadendorf, and Klaus Cichutek
Blood 2006; 107: 1476-1483.
[Abstract]
[Full text]
[PDF]
Tumor rejection by the poliovirus receptor family ligands of the DNAM-1 (CD226) receptor
- Satoko Tahara-Hanaoka, Kazuko Shibuya, Hirayasu Kai, Akitomo Miyamoto, Yoshihiro Morikawa, Nobuhiro Ohkochi, Shin-ichiro Honda, and Akira Shibuya
Blood 2006; 107: 1491-1496.
[Abstract]
[Full text]
[PDF]
Frequency of telomerase-specific CD8+ T lymphocytes in patients with cancer
- Gilberto Filaci, Marco Fravega, Maurizio Setti, Paolo Traverso, Enrico Millo, Daniela Fenoglio, Simone Negrini, Francesca Ferrera, Andrea Romagnoli, Monica Basso, Paola Contini, Marta Rizzi, Massimo Ghio, Umberto Benatti, Gianluca Damonte, Jean Louis Ravetti, Giorgio Carmignani, Maurizio Zanetti, and Francesco Indiveri
Blood 2006; 107: 1505-1512.
[Abstract]
[Full text]
[PDF]
Use of trifunctional bispecific antibodies to prevent graft versus host disease induced by allogeneic lymphocytes
- Shoshana Morecki, Horst Lindhofer, Elena Yacovlev, Yael Gelfand, and Shimon Slavin
Blood 2006; 107: 1564-1569.
[Abstract]
[Full text]
[PDF]
Generation of biologically active linear and cyclic peptides has revealed a unique fine specificity of rituximab and its possible cross-reactivity with acid sphingomyelinase-like phosphodiesterase 3b precursor
- Federico Perosa, Elvira Favoino, Maria Antonietta Caragnano, and Franco Dammacco
Blood 2006; 107: 1070-1077.
[Abstract]
[Full text]
[PDF]
|
|
